Mallinckrodt
Mary Culkin has extensive experience in the pharmaceutical industry, with a career spanning over 25 years. Mary most recently held the position of Vice President Global Quality at Mallinckrodt Pharmaceuticals since July 2023. Prior to that, they worked as a Senior Quality Executive at Ireland starting in November 2018.
Previously, Mary held various leadership roles at BMS Global, BMS Biologics Cruiserath, Alexion, Pfizer, and Vistakon, Johnson & Johnson. These roles included Head of Biologics Quality Internal Sites, Site Quality Director, Head of Quality Ireland, Executive Director External Quality Assurance, and Head of QA Operations Drug Substance and Parenterals.
Additionally, Mary has experience as a Consultant at MC Consulting from 2000 to 2007.
Overall, Mary Culkin has demonstrated a strong track record in quality management and leadership within the pharmaceutical industry.
Mary Culkin attended Trinity College, but no information is provided regarding the years of enrollment, degree pursued, or field of study.
This person is not in any offices
Mallinckrodt
11 followers
Mallinckrodt develops, manufactures, markets and distributes innovative treatments for underserved patient populations within neurology, rheumatology, nephrology, pulmonology, and ophthalmology.